Cargando…
TBX2 subfamily suppression in lung cancer pathogenesis: a high-potential marker for early detection
The TBX2 subfamily (TBXs 2, 3, 4 and 5) transactivates or represses genes involved in lung organogenesis. Yet TBX2 subfamily expression in pathogenesis of non-small cell lung cancer (NSCLC), the most common lung malignancy, remains elusive. We sought to probe the expression profile of the TBX2 subfa...
Autores principales: | Khalil, Athar A., Sivakumar, Smruthy, Lucas, Frances Anthony San, McDowell, Tina, Lang, Wenhua, Tabata, Kazuhiro, Fujimoto, Junya, Yatabe, Yasushi, Spira, Avrum, Scheet, Paul, Nemer, Georges, Kadara, Humam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620251/ https://www.ncbi.nlm.nih.gov/pubmed/28978111 http://dx.doi.org/10.18632/oncotarget.19938 |
Ejemplares similares
-
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes
por: Khalil, Athar, et al.
Publicado: (2018) -
Epigenetic Suppression of the T-box Subfamily 2 (TBX2) in Human Non-Small Cell Lung Cancer
por: Nehme, Eliana, et al.
Publicado: (2019) -
Strategies for identification of somatic variants using the Ion Torrent deep targeted sequencing platform
por: Deshpande, Aditya, et al.
Publicado: (2018) -
Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung
por: Sivakumar, Smruthy, et al.
Publicado: (2019) -
A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases
por: Khalil, Athar, et al.
Publicado: (2017)